VPAC1R modulators (Audeo Oncology/University of Queensland)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVPAC1R modulators (Audeo Oncology/University of Queensland)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasoactive intestinal polypeptide receptor 1 modulators
TargetsVasoactive intestinal polypeptide receptor 1
Therapy Area/IndicationsRespiratory Tract DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAudeo Oncology IncThe University Of Queensland
Active IndicationsN/A
Inactive IndicationsRespiratory Tract DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A